TLDR

MARKET RECAP → Stocks edged higher on Tuesday, with the S&P 500 (VOO) and Nasdaq (QQQ) reaching new record highs, as investors anticipated Nvidia’s (NVDA) earnings report on Wednesday, a favorite in the AI sector (and, well, every investor it seems).

JOHANSSON VS. OPENAI → 🎤 Scarlett Johansson accused OpenAI of using AI to mimic her voice from the movie “Her” without permission, raising legal and ethical concerns over AI-generated content.

HIM & HERS INTRODUCES NEW INJECTIONS → 💉 Hims & Hers launched GLP-1 injections for weight loss and diabetes, boosting stock prices with their new, safe, and accessible treatment option.

Was this email forwarded to you? Sign up for free here.

MARKETS

Today’s S&P 500 Heatmap

Notable Earnings This Week

TODAY’S TOP NEWS

Johansson VS. OpenAI

🎤 Voice Imitation Controversy: Scarlett Johansson accused OpenAI of using her voice without permission. The actress claimed that an AI model trained by OpenAI replicated her voice from the movie “Her”, leading to unauthorized use in various applications.

⚖️ Legal and Ethical Issues: Johansson’s legal team argued that this usage violated her rights and called for stricter regulations on AI-generated content. This case highlights the growing concerns over AI ethics and intellectual property rights in the digital age.

🌐 Broader Implications: The dispute underscores the challenges in balancing innovation with personal rights. It has sparked a broader debate about the need for legal frameworks to address the use of AI in media and entertainment.

TODAY’S TOP NEWS

HIMS & HERS Introduces New Injections

💉 Launch of Compounded GLP-1 Injections: Hims & Hers announced the launch of compounded GLP-1 injections, aimed at providing a new treatment option for weight management and type 2 diabetes. This move represents a significant expansion in their product offerings, targeting a growing market demand for effective weight loss solutions.

📈 Positive Market Reaction: The introduction of these new injections has been met with positive market response, boosting investor confidence and leading to a rise in Hims & Hers' stock price. Analysts are optimistic about the potential impact on the company’s revenue, given the increasing prevalence of obesity and diabetes.

🔬 Focus on Safety and Accessibility: Hims & Hers emphasized their commitment to safety and regulatory compliance, ensuring that the compounded GLP-1 injections meet all necessary guidelines. The company aims to make these treatments widely accessible while maintaining high standards of patient care and efficacy.

BULL VS. BEAR

NOTABLE POSTS

KEEP READING

Fed Governor Waller wants ‘several months’ of good inflation data before lowering rates (CNBC)

One dead, 30 injured as Singapore Airlines flight encounters severe turbulence (CNBC)

Tech giants pledge AI safety commitments — including a ‘kill switch’ if they can’t mitigate risks (CNBC)

Lowe’s beats on earnings and revenue, even as consumers spend less on DIY projects (CNBC)

Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users (CNBC)

Short seller alleges Oddity Tech is misleading investors (CNBC)

Jamie Dimon is worried about how much the US is borrowing. Here’s why (CNN)

Microsoft thinks it found a way to make PCs relevant again (CNN)

How to Turn $100 Into $1,000 (ML)

Is It Possible To Have a 900 Credit Score? (ML)

MoneyLion: On a Mission to Become the Expedia of Financial Services (PYMNTS)

WHAT WE’RE WATCHING

OUR FAVORITE TOOLS & RESOURCES

• Perplexity — Perplexity AI is an AI-chatbot-powered research and conversational search engine

• The Market Ear — Live news, analysis and commentary on what moves markets and trading

• Coinmarketcap.com — Crypto market data

• Finviz — Financial visualizations

• Trading Economics — Economic calendar

• CME FedWatch Tool — Market-implied probabilities of future levels of interest rates 

• Dataroma — Track stock picks and portfolios of legendary value investors such as Warren Buffett

• ChatGPT — Large language model-based chatbot powered by generative AI

• Notion AI — Notion AI is a writing assistant that can help you write, brainstorm, edit, summarize, and more

• Vimcal — Lightning-fast calendar and AI scheduling assistant

The Bull vs. Bear Merchandise Promotion is a limited time campaign that begins on December 1, 2023 at 12:00 AM ET and ends on the date that there are no more Rewards. This Promotion is available to any registered MoneyLion user who is a legal resident of the 50 United States or the District of Columbia and who has reached the age of majority in their state as of the beginning of the Promotional Period. See terms and conditions here.

This advertising email was sent to you because you have a MoneyLion account. If you would like to unsubscribe, please do so using this link. We respect your right to privacy. Please do not reply to this email with sensitive information, such as an account number, Social Security number, date of birth, bank account information, PIN, password, or Online ID. The security and confidentiality of your personal information is important to us. If you have any questions or want to read more, please visit our Help Center.

MoneyLion and Pathward do not provide, nor do they guarantee, any third-party product, service, information, or recommendation. The third parties providing these products or services are solely responsible for them, as well as all other content on their websites. MoneyLion is not liable for any third party’s failure with regard to those advertised products, services, and benefits. These advertised products and services may not be FDIC insured or bank-guaranteed, and may be subject to a different privacy policy than MoneyLion’s. You should check individual offers, products, and services to become familiar with any applicable restrictions or conditions that may apply. MoneyLion may receive compensation from third parties for referring you to the third party, their products or to their website.

The influencer, creator and other content provided in the MoneyLion App (“Content”) is for informational and entertainment purposes only and should not be construed as legal, tax, investment, financial, or other advice. All Content is intended to be of a general nature, does not address the circumstances of any particular individual or entity, and may not constitute a comprehensive or complete statement of the matters discussed. MoneyLion is not a fiduciary by virtue of any person’s use of or reliance on the Content. You should consult an appropriate professional if you require any legal, tax, investment, financial or other advice.